Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis

Ting Tse Lin, Jiun Yang Chiang, Min Tsun Liao, Chia Ti Tsai, Juey Jen Hwang, Fu Tien Chiang, Jiunn Lee Lin, Lian Yu Lin

研究成果: 雜誌貢獻文章

8 引文 斯高帕斯(Scopus)

摘要

Current evidence suggests that beta-blocker lower the risk of development of atrial fibrillation (AF) and in-hospital stroke after cardiac surgery. This study was to assess whether beta-blockers could decrease incidence of new-onset AF in patients with end stage renal disease (ESRD). We identified patients from a nation-wide database called Registry for Catastrophic Illness, which encompassed almost 100% of the patients receiving dialysis therapy in Taiwan from 1995 to 2008. Propensity score matching and Cox € s proportional hazards regression model were used to estimate hazard ratios (HRs) for new-onset AF. Among 100066 patients, 41.7% received beta-blockers. After a median follow-up of 1500 days, the incidence of new-onset AF significantly decreased in patients treated with beta-blockers (HR = 0.483, 95% confidence interval = 0.437-0.534). The prevention of new-onset AF was significantly better in patients taking longer duration of beta-blockers therapy (P for time trend <0.001). The AF prevention effect remains robust in subgroup analyses. In conclusion, beta-blockers seem effective in the primary prevention of AF in ESRD patients. Hence, beta-blockers may be the target about upstream treatment of AF.
原文英語
文章編號17731
期刊Scientific Reports
5
DOIs
出版狀態已發佈 - 十二月 8 2015
對外發佈Yes

ASJC Scopus subject areas

  • General

指紋 深入研究「Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis」主題。共同形成了獨特的指紋。

  • 引用此